Monthly Archives: February 2020

A leading research firm, Zion Market Research added a latest industry report on "Global Complementary and Alternative Medicine Market" consisting of 110+ pages during the forecast period and Complementary and Alternative Medicine Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Complementary and Alternative Medicine Market.

According to the report the Global Complementary and Alternative Medicine Market Is Set For Swift Growth, To Reach Around USD 163.3 Billion by 2025

The Complementary and Alternative Medicine Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. The report covers the global Complementary and Alternative Medicine Market performance in terms of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and opportunities influencing revenue growth of the global consumer electronics market.This report studies the global Complementary and Alternative Medicine Market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Complementary and Alternative Medicine Market by companies, region, type and end-use industry.

Request a Free Sample Report on Complementary and Alternative Medicine Market:https://www.zionmarketresearch.com/sample/complementary-and-alternative-medicine-market

The Complementary and Alternative Medicine Market report mainly includes the major company profiles with their annual sales & revenue, business strategies, company major products, profits, industry growth parameters, industry contribution on global and regional level.This report covers the global Complementary and Alternative Medicine Market performance in terms of value and volume contribution. This section also includes major company analysis of key trends, drivers, restraints, challenges, and opportunities, which are influencing the global Complementary and Alternative Medicine Market. Impact analysis of key growth drivers and restraints, based on the weighted average model, is included in this report to better equip clients with crystal clear decision-making insights.

The Complementary and Alternative Medicine Market research report mainly segmented into types, applications and regions.The market overview section highlights the Complementary and Alternative Medicine Market definition, taxonomy, and an overview of the parent market across the globe and region wise.To provide better understanding of the global Complementary and Alternative Medicine Market, the report includes in-depth analysis of drivers, restraints, and trends in all major regions namely, Asia Pacific, North America, Europe, Latin America and the Middle East & Africa, which influence the current market scenario and future status of the global Complementary and Alternative Medicine Market over the forecast period.

Get Free PDF Brochure of this Report: https://www.zionmarketresearch.com/requestbrochure/complementary-and-alternative-medicine-market

The Complementary and Alternative Medicine Market report provides company market size, share analysis in order to give a broader overview of the key players in the market. Additionally, the report also includes key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market on the global and regional basis.

Major Company Profiles Covered in This Report:

Herb Pharm, Herbal Hills, Columbia Nutritional Inc., Deepure Plus, Helio USA Inc., Pure encapsulations, Inc., Nordic Naturals, and other wellness institutes like John Schumachers Unity Woods Yoga Center, Iyengar Yoga Institute, The Healing Company, Yoga Tree, and Quantum Touch Inc. among others.

Some of the major objectives of this report:

1) To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Complementary and Alternative Medicine Market.

2. To provide insights about factors affecting the market growth. To analyze the Complementary and Alternative Medicine Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.

3. To provide historical and forecast revenue of the Complementary and Alternative Medicine Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.

4. Country level analysis of the market with respect to the current market size and future prospective.

5. To provide country level analysis of the market for segment by application, product type and sub-segments.

6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

7. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Complementary and Alternative Medicine Market.

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the clients needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to usafter allif you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll Free No.1-855-465-4651

Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Sorry! The Author has not filled his profile.

See the rest here:

Global Complementary and Alternative Medicine Market Is Set For Swift Growth, To Reach Around USD 163.3 Billion by 2025 - Global Newspaper 24

To the Editor:

Re Whos Afraid of Gwyneth Paltrow? (Op-Ed, Feb. 4):

No one is afraid of Ms. Paltrow and her company, Goop. What people fear is the very real, very dangerous reality that we live in: a post-Enlightenment culture that eschews facts in favor of subjective narrative.

Anti-vax is real. Cancer patients dying because of alternative medicine is real. Global warming denialism is real.

If Elisa Albert and Jennifer Block want Ms. Paltrows imaginative treatments and practices to be viewed as seriously as science-based medicine, then they can subject those practices to rigorous, public scientific inquiry. No one is stopping them.

And a deserved patriarchal beat-down? Many of the finest and most scathing critiques of these anti-science techniques come from very qualified women whose feminist credentials and real-life clinical experience are beyond reproach.

This is not about empowerment. This is good old anti-science nonsense at a time when we can least afford it.

Stephen BellingerPacifica, Calif.

To the Editor:

Its about time that an article appeared that stands up to patriarchal science and medicine for minimizing the feminine, time-tested, results-driven approach to health and the wellness of our bodies.

There is no stopping the power of the more natural, feminine approach to life. Look how far yoga and eating more healthfully have come since the 1960s.

Now with the power of the internet, just maybe the feminine will rise to equal status and respect in every area of life. And what a better, more beautiful, harmonious and balanced life it will be!

Joy FreemanSan DiegoThe writer is the author of 7 Keys to Connection: How to Move Beyond the Physical and Emotional Trauma of a Disconnected Culture.

To the Editor:

Equating the rejection of Gwyneth Paltrows goofy pseudoscientific Goop products and practices with womens struggle to be recognized within science and medicine is exactly why we women are not taken seriously.

With the current climate of misogynistic thinking we cannot afford more stuff and nonsense, especially like Yoni eggs and vagina steaming.

Joy MottAlderson, W. Va.

To the Editor:

Re Recording Undercuts Presidents Claims (front page, Jan. 26):

President Trump was recorded as stating that the European Union is a group of countries that got together to screw the United States, its as simple as that. Unsurprisingly perhaps, this statement is uninformed and untrue.

At least from Secretary of State George C. Marshalls announcement in June 1947 of what became the Marshall Plan, United States policy has encouraged the European countries to cooperate with one another, first as aid recipients, then as alliance partners and soon thereafter as architects of their own integration.

They did this in their own construction of the European Economic Community between 1950 and 1957, the precursor in all but name of todays European Union.

Charles S. MaierCambridge, Mass.The writer is a research professor of history at Harvard.

To the Editor:

In Closing the Court of History (Op-Ed, Feb. 5), Matthew Connelly expresses concern about records deleted within federal agencies after a set time instead of being transferred into the National Archives and Records Administration.

Having worked on site with officials in federal agencies early in my NARA career to appraise paper records for transfer into the National Archives, I know that some 3 percent of federal records warrant designation as historical. This remains the case with electronic records.

As in the past, NARA can reassess federal records cleared for destruction 7, 25 or 75 years after creation as deletion dates near. Presidential records fall under a separate law. Ive worked on several moves of White House records to NARA. Since some 90 to 95 percent of President Barack Obamas presidential records were born digital (no paper version filed), he and NARA agreed there was no need to construct a separate presidential library building.

Rather, NARA employees hold President Obamas records (digital and paper) in its existing facilities for processing under a law passed in 1978.

Maarja KrustenWashington

Link:

Gwyneth Paltrows Goop Arts, and Science - The New York Times

The Complementary And Alternative Medicine Market report has been generated by strictly following commitments and deadlines to deliver the finest market report. This global market report deals with a number of industry and market parameters including market segmentation, new market entry, top players, latest trends, industry forecasting, target market analysis, future directions, strategic analysis, opportunity identification, insights and innovation.

Being a comprehensive in nature, Complementary And Alternative Medicine Market research report gives intelligent information about different market segments on which businesses are highly depending for thriving in the market. This report is significant, unique, and creditable market reports which is formed by focusing on specific business requirements.

The report provides detailed discussion about the Complementary And Alternative Medicine market major drivers, restraints, challenges, opportunities, risk analysis. Complementary And Alternative Medicine Market report combines data integration and analysis with relevant findings to predict strong future growth. The Complementary And Alternative Medicine Market report focuses on key regions, product sales, new product launches, producrtion capacity, demand, market share, and growth value. It also offers a transparent picture of companies to the readers for better understanding the Market situation. Complementary And Alternative Medicine market report also highlights the political scenario in the market.

The key players involved in the Complementary And Alternative Medicine Market are: Herbal Hills, Columbia Nutritional Inc., Nordic Naturals, Deepure Plus, Herb Pharm, Helio uSA Inc. and Pure encapsulations Inc..

For Better Understanding, Download Free Sample Copy Of Complementary And Alternative Medicine Market Report At:https://marketresearch.biz/report/complementary-and-alternative-medicine-market/request-sample

[***Are You A Start-Up, On The Way To Make It Vast? Grab an Exclusive Sample Copy Here***]

The scope of the Global Complementary And Alternative Medicine Report:

Market representation: main players, analysis, size, a situation of the business, SWOT analysis 2020 to 2029.

Regional scope: North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc), South America (Brazil; Argentina etc), Middle East & Africa (Saudi Arabia; South Africa etc)

Methodology: A mixture of primary and secondary research

Report coverage: opportunities, challenges, statistics, drivers, restraints, limits, market size, share, and trends.

Forecast period: 2020 2029 | History 2013-2019

What the Report has in Store for you?

* Industry Size & Forecast: The industry analysts have offered historical, current, and forecast of the industry size with the value and volume.

* Future Opportunities: This section provide the information on the future prospects that the Complementary And Alternative Medicine is likely to offer.

* Industry Trends & Developments: Here, report have covers the major trends and developments taking place in the Complementary And Alternative Medicine marketplace and their estimated impact on the overall growth.

* Study on Industry Segmentation: Detailed breakdown of the key Complementary And Alternative Medicine segments including product type, application, and vertical has been done in this portion of the report.

* Regional Analysis: Complementary And Alternative Medicine vendors are offered crucial information of the high growth regions and their respective countries, thus helping them to invest in profitable regions.

* Competitive Landscape: This section of the report spot light on the competitive scenario of the Complementary And Alternative Medicine by focusing on the key strategies taken up by the vendors to consolidate their presence in the Complementary And Alternative Medicine business.

* Analysis on Strategies of Leading Players: Market players can use this analysis to gain competitive advantage over their competitors in the Complementary And Alternative Medicine market.

Research Approach:

Our analysts have used improved primary and secondary research tools to compile this report using top-down and bottom-up approaches and further analyzed using analytical tools such as porters five force analysis. The research sources and tools that we use are highly reliable and trustworthy. The report offers effective guidelines and recommendations for players to secure a position of strength in the Complementary And Alternative Medicine market. New players can also use this research study to create business strategies and get informed about future market challenges. We provide a comprehensive competitive analysis that includes detailed company profiling of leading players, a study on the nature and characteristics of the vendor landscape, and other important studies.

Customize Report AndInquiry For The Complementary And Alternative Medicine Market Report:https://marketresearch.biz/report/complementary-and-alternative-medicine-market/#inquiry

You can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Country like US, UK, china and other.

About Us:

MarketResearch.biz Reports provides syndicated market research on industry verticals including Technology and Media, Healthcare, Information and Communication Technology (ICT), Chemicals, Materials, Energy, Heavy Industry, etc. MarketResearch.biz provides global and regional market intelligence coverage, a 360-degree market view which includes competitive landscape, statistical forecasts, detailed segmentation, key trends, and strategic recommendations.

Contact Us At

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876

Website:https://marketresearch.biz

Email ID:inquiry@marketresearch.biz

Continued here:

Global Complementary And Alternative Medicine Market Present Key Players, Business Overview, Trends, Demand and Opportunities Forecast 2029 - Sound On...

Dataintelo.com, has added the latest research on AYUSH and Alternative Medicine Market, which offers a concise outline of the market valuation, industry size, SWOT analysis, revenue approximation, and the regional outlook of this business vertical. The report precisely features the key opportunities and challenges faced by contenders of this industry and presents the existing competitive setting and corporate strategies enforced by the AYUSH and Alternative Medicine Market players.

As per the AYUSH and Alternative Medicine Market report, this industry is predicted to grow substantial returns by the end of the forecast duration, recording a profitable yearly growth in the upcoming years. Shedding light on brief of this industry, the report offers considerable details concerning complete valuation of the market as well as detailed analysis of the AYUSH and Alternative Medicine Market along with existing growth opportunities in the business vertical.

Request a sample Report of AYUSH and Alternative Medicine Market at: https://dataintelo.com/request-sample/?reportId=94639

Concepts and ideas in the report:Analysis of the region- based segment in the AYUSH and Alternative Medicine Market: As per the report, in terms of provincial scope, the AYUSH and Alternative Medicine Market is divided into USA, Europe, Japan, China, India and South East Asia. It also includes particulars related to the products usage throughout the geographical landscape. Data related to the evaluations held by all the zones mentioned as well as the market share registered by each region is included in the report. Sum of all the product consumption growth rate across the applicable regions as well as consumption market share is described in the report. The report speaks about consumption rate of all regions, based on product types and applications.

Brief of the market segmentation: As per the product type, the AYUSH and Alternative Medicine Market is categorized intoAyurvedic MedicinesHerbal MedicinesAroma TherapyHomeopathyReflexologyOthers

Furthermore, the market share of each product along with the project valuation is mentioned in the report. The report consists of facts related to every single products sale price, revenue, growth rate over the estimation time period.

The AYUSH and Alternative Medicine Market, according to the application spectrum, is categorized intoWomenMenKids

Data pertaining the market share of each product application as well as estimated revenue that each application registers for is slated in the report.

Propelling factors & challenges: The report provides data concerning the forces influencing the commercialization scale of the AYUSH and Alternative Medicine Market and their effect on the revenue graph of this business vertical. Data pertaining to latest trends driving the AYUSH and Alternative Medicine Market along with the challenges this industry is about to experience in the upcoming years is mentioned in the report.

Ask for Discount on AYUSH and Alternative Medicine Market Report at: https://dataintelo.com/ask-for-discount/?reportId=94639

Implementing marketing tactics: Ideas about numerous marketing strategies implemented by the renowned shareholders with respect to product marketing is present in the report. Information related to the sales channels that companies select is also included in the report. Along with the dealers of these products, it also presents the summary of the top customers for the same.

Analysis of the major competitors in the market:An outline of the manufacturers active in the AYUSH and Alternative Medicine Market, consisting ofBaidyanathHimalya HerbalsGanga PharmaceuticalsPatanjaliHamdardalong with the distribution limits and sales area is reported. Particulars of each competitor including company profile, overview, as well as their range of products is inculcated in the report. The report also gives importance to product sales, price models, gross margins, and revenue generations. The AYUSH and Alternative Medicine Market report consists of details such as estimation of the geographical landscape, study related to the market concentration rate as well as concentration ratio over the estimated time period.

To Buy this report, Visit : https://dataintelo.com/checkout/?reportId=94639

Some of the Major Highlights of TOC covers:AYUSH and Alternative Medicine Regional Market Analysis AYUSH and Alternative Medicine Production by Regions Global AYUSH and Alternative Medicine Production by Regions Global AYUSH and Alternative Medicine Revenue by Regions AYUSH and Alternative Medicine Consumption by Regions

AYUSH and Alternative Medicine Segment Market Analysis (by Type) Global AYUSH and Alternative Medicine Production by Type Global AYUSH and Alternative Medicine Revenue by Type AYUSH and Alternative Medicine Price by Type

AYUSH and Alternative Medicine Segment Market Analysis (by Application) Global AYUSH and Alternative Medicine Consumption by Application Global AYUSH and Alternative Medicine Consumption Market Share by Application (2014-2019)

AYUSH and Alternative Medicine Major Manufacturers Analysis AYUSH and Alternative Medicine Production Sites and Area Served Product Introduction, Application and Specification AYUSH and Alternative Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) Main Business and Markets Served

For More Information on this report, Request Inquiry At https://dataintelo.com/enquiry-before-buying/?reportId=94639

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataIntelo Name Alex Mathews Email [emailprotected] Website https://dataintelo.com Address 500 East E Street, Ontario, CA 91764, United States.

Read the original post:

Global AYUSH and Alternative Medicine Market Business Analysis 2019 by CAGR, Share, Revenue and Prominent Key Players to 2025 - News Times

DUBLIN, Feb. 14, 2020 /PRNewswire/ -- The "Postoperative Pain - Market Insights, Epidemiology and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.

The Postoperative Pain Report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Postoperative Pain in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.

The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Postoperative Pain from 2017 to 2028 segmented by seven major markets. The report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Postoperative Pain Epidemiology

According to the review article by Tong J Gen (2017), surgery and anesthesia are critical health care services that reduce the risk of death and disability among millions worldwide each year, and the need for these services is expected to continue to increase over the next decade. Globally, nearly 313 million operations were performed in 2012. Although possibly life-saving, surgery is also related to potential harm, which normally includes pain during and after the procedure.

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology scenario of Postoperative Pain in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028 for the following aspects:

The disease epidemiology covered in the report is segmented by:

As per the analysis, in 2017 the total number of incident cases of postoperative pain in the US was 40,314,731. The main reasons behind increased cases are due to increase morbidity, reduced physical function and quality of life, increased cost of care, bad recovery, preexisting pain, and prolonged opioid use during and after hospitalization.

Further, according to the publisher, in 2017, it is estimated that the severity-specific incident cases of postoperative pain in France were 1,194,644, 1,439,003 and 828,105 in mild, moderate and severe cases respectively. Additionally, Japan was observed with 12,134,677 incident cases for postoperative pain in 2017.

A study was conducted by Marinangeli et al. (2009) to know the treatment of acute pain in the prehospital emergency setting remains a significant problem. The study evaluated the incidence, site, and possible cause of acute pain in the prehospital period and also the current state of prehospital pain management by assessing analgesic availability in emergency vehicles in Italy. The study concluded that pain symptoms were present in approximately two-thirds of the patients (n = 383) and ranked as moderate to unbearable in 41.75%.

Results of the analgesic availability survey specify that 10.6% of the ambulance services carry no pain killers (including nonsteroidal anti-inflammatory drugs [NSAIDs] and/or paracetamol) and 11.5% are without an opioid. The pain evaluation was calculated which showed that 32.5% had no pain, 22% showed slight pain, 26.5% showed moderate pain, 12% patient felt severe pain, 3.25% patient could not bear the pain, and 3.75% patient were not defined in the scale (Marinangeli et al., 2009).

Postoperative Pain Drug Chapters

This segment of the Postoperative Pain report encloses a detailed analysis of the drugs that are expected to be launched in other regions. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Expected launch of potential therapies may increase the market size in the coming years, assisted by an increase in the prevalent population of Postoperative Pain and awareness of the disease. The overall dynamics of the Postoperative Pain market is anticipated to change in the coming years owing to the expected launch of emerging therapies that are already approved in specific regions but are expected to be launched in other regions as well. The major key players such as Heron Therapeutics, Cara Therapeutics, Trevena and others will significantly increase the market during the forecast period (2019-2028).

Postoperative Pain Market Outlook

Currently, the treatment pattern consists of different classes of drugs that are classified into pharmacologic and nonpharmacological therapies. The pharmacological therapies include analgesics that are further segregated into opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen respectively. The acute pain is also managed by the use of benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids.

Further, nonpharmacological therapies include acupuncture, psychological approaches (cognitive behavioral therapy, mindfulness-based stress reduction), chiropractic manipulation, physical therapy, transcutaneous electrical stimulation, massage therapy, exercise, and other complementary and alternative medicine therapies (CAM).

Opioids are a large group of pain-relieving drugs that are used for reducing the pain in the postoperative cases. These drugs majorly include fentanyl, hydromorphone, morphine, oxycodone, oxymorphone, and tramadol. Also, non-steroidal anti-inflammatory drugs (NSAIDs) are a sensible choice because of their effectiveness after surgical procedures. However, before surgeons start prescribing NSAIDs in place of opioids, it is crucial first to understand their potential post-surgical complications.

NSAIDs provide anti-inflammatory, antipyretic, analgesic and thrombotic effects through the inhibition of the enzymes cyclooxygenases 1 and 2 (COX-1 and COX-2). Although several generics are available for NSAIDs and presence of generics in the market is due to patent expiration. Paracetamol is the most commonly used analgesic with analgesic and antipyretic action. Even though it has been widely available for a long time, its exact mechanism of action is still unknown.

In addition to this, in September 2015, Zalviso was approved by the European Commission (EC) for the management of acute moderate-to-severe pain in adult patients in the hospital setting. The drug is a synthetic, potent opioid with highly selective binding to -opioid receptors. Another approved drug in the European Union is Maxigesic, which is approved in Austria, Belgium, Croatia, France, Germany, Luxembourg, Netherlands, Portugal, and Spain in May 2017. The drug reduces fever and provides temporary relief of pain associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, sore throat, arthritis, tennis elbow, period pain, muscular pain, rheumatic pain, aches and pains associated with colds and flu.

Dsuvia is an opioid agonist contains sufentanil and is indicated for use in adults in a certified medically supervised healthcare setting, such as hospitals, surgical centers, and emergency departments, for the management of acute pain. Dsuvia is administered in the form of the tablet sublingually to the patient. Also, it is approved as a brand name Dzuveo in Europe and is effective in reducing severe pain following surgeries.

The postoperative pain pipeline possesses potential drugs in late and mid developments to be launched in the near future. The major key players include Olinvo (Trevena), HTX-011 (Heron Therapeutics), and CR845/Difelikefalin (Cara Therapeutics).

Olinvo (Trevena) is a novel G protein biased (selective) mu-opioid receptor (MOR) ligand which is in development for the management of moderate-to-severe acute pain in hospitals or other controlled clinical settings where IV opioid therapy is warranted. The drug is currently in phase III clinical developmental trial.

Heron Therapeutics is developing a potent drug HTX-011 (bupivacaine and meloxicam) which is in phase III developmental trial. The drug is a fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam. In December 2018, the US FDA accepted the new drug application (NDA) for HTX-011 and also granted a Priority Review designation.

This segment gives a thorough detail of market trend of each therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to the publisher, the market of Postoperative Pain in the 7MM is expected to change from 2019-2028.

Postoperative Pain Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Approval of therapies for Postoperative Pain such as Maxigesic (AcelRx Pharmaceuticals; to be launched in US and Japan), HTX-011 (Heron Therapeutics; to be launched in US, EU and Japan), Olinvo (Trevena; to be launched in US, EU and Japan), CR845 (Cara Therapeutics; to be launched in US, EU and Japan), and other targeted therapies in the forecast period [2019-2028] will also create a positive impact on the Postoperative Pain market.

The market is anticipated to show an extensive boost due to projected label expansion of the current therapies and emergence of potential pipeline products as approved therapies in the near future. The market size of Postoperative in the seven major markets in 2017 was USD 1,067.82 Million in 2017. Japan accounts for the least market size in the 7MM during the forecast period 2017-2028, at a CAGR of 7.41% for the study period (2017-2028). Among the EU5 countries, Germany had the highest market size with USD 49.89 Million in 2017, while Spain had the lowest market size of postoperative pain.

Report Insights

Key Strengths

Report Assessment

Key Benefits

Companies Mentioned

Key Topics Covered

1. Key Insights

2. Postoperative Pain Market Overview at a Glance2.1. Market Share (%) Distribution of Postoperative Pain in 20172.2. Market Share (%) Distribution of Postoperative Pain in 2028

3. Disease Background and Overview: Postoperative Pain3.1. Introduction3.2. Transition from Acute to Chronic Pain3.2.1. Elective or Planned Procedures3.2.2. Common Types of Acute Postoperative Pains3.3. Pathophysiology of Acute Pain3.3.1. Formation of reflexes in postoperative pain3.3.2. Negative effects of postoperative pain on various organ systems3.3.3. Psychological effects of postoperative pain3.3.4. Late effects of insufficient postoperative analgesia3.3.5. Chronic postoperative pain3.4. Factors affecting postoperative pain3.5. Diagnosis of Postoperative Pain3.5.1. Medical history, physical examination, and specific evaluation of pain3.5.2. Measuring pain3.5.3. Various Grading Scales used for Diagnosis of Acute Pain3.5.4. Verbal methods of pain assessment3.5.5. Multidimensional methods of pain assessment3.5.6. Nonverbal methods of pain assessment3.6. Diagnostic Algorithm3.7. Guidelines3.7.1. Guidelines on the Management of Postoperative Pain3.7.2. Goals and Elements of the Initial Assessment

4. Epidemiology and Patient Population4.1. Key Findings4.2. Total number of Incident cases of Postoperative Pain in the 7MM

5. Epidemiology of Postoperative Pain in the 7MM5.1. Assumptions and Rationale5.2. United States5.2.1. Total number of surgical procedures in the US5.2.2. Total number of Postoperative Pain Incident cases in the US5.2.3. Severity-specific Postoperative Pain incident cases in the US5.3. Germany5.4. France5.5. Italy5.6. Spain5.7. United Kingdom5.8. Japan

6. Treatment6.1.1. Pharmacological Therapies6.1.2. Multimodal analgesia6.1.3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)6.1.4. Opioids6.1.5. Non-opioid analgesics6.1.6. Procedure-specific analgesia6.1.7. Regional anesthesia6.1.8. Non-Pharmacological Methods to Treat Acute Pain6.1.9. Physical methods6.1.10. Intravenous Patient-Controlled Analgesia (PCA)6.1.11. Nerve Blocks6.1.12. Pediatric Pain Management6.2. Treatment Algorithm for Acute Postoperative Pain

7. Guidelines for Acute Pain7.1.1. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy (2017)7.1.2. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council (2017)

8. Unmet Needs

9. Marketed Drugs9.1. Marketed Drugs Key-cross Competition9.2. Zalviso: AcelRx Pharmaceuticals9.2.1. Product Description9.2.2. Regulatory Milestones9.2.3. Other Developmental activities9.2.4. Clinical Development9.2.5. Safety and Efficacy9.2.6. Product Profile9.3. Maxigesic: AFT Pharmaceuticals9.4. Dsuvia/Dzuveo (Sufentanil): AcelRx Pharmaceuticals9.5. Dexketoprofen Tramadol: Menarini Group

10. Emerging Drugs10.1. Key Cross Competition10.2. Olinvo (Oliceridine injection or TRV130): Trevena10.2.1. Product Description10.2.2. Other Development Activities10.2.3. Clinical Development10.2.4. Safety and Efficacy10.2.5. Product Profile10.3. HTX-011: Heron Therapeutics10.4. CR845/Difelikefalin: Cara Therapeutics10.5. NTM-001: Neumentum Pharmaceuticals10.6. PF-05089771: Pfizer

11. Postoperative Pain: 7 Major Market Analysis11.1. Key Findings11.2. Forecasting Parameters11.3. Market Size of Postoperative Pain in the 7MM Countries

12. 7MM Market Outlook12.1. Expected Approval: Emerging Therapies12.2. United States12.2.1. Total Market size of Postoperative Pain12.2.2. Market Size by Therapies12.3. Germany12.4. France12.5. Italy12.6. Spain12.7. United Kingdom12.8. Japan Market Size

13. Market Drivers

14. Market Barriers

For more information about this report visit https://www.researchandmarkets.com/r/ita38l

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more:

Postoperative Pain Industry Outlook, 2020-2028 - Approval of Therapies such as Maxigesic, HTX-011, Olinvo, CR845 Will Create a Positive Impact on the...

Propolis Market: An Overview

The propolis market is expected to witness robust growth during 2018-2026. Propolis is a drug on the rise for a wide variety of assumed and proven benefits. Propolis embeds a special compound called pinocembrin. This flavonoid works as an antifungal with its anti-inflammatory properties and antimicrobial properties. The medicine is widely used for its ability to help heal major wounds. Studies continue to support the use of propolis to treat severe burn victims. The drug also trends popularly, thanks to its mythical properties arising from folk lore. Many people also believe it is helpful in curing cancer. While these beliefs are not yet confirmed with research, both the beliefs and actual benefits continue to drive significant growth for the propolis market.

Download Brochure of This Market Report at https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6079

Propolis Market: Notable Developments

Wedderspoon, one of the largest honey brand in the United States has launched a new line of Propolis products. These health honey products are throat sprays are a new line of natural products which are rising in demand worldwide. The sprays are touted as functional well product lines. These sprays are marketed as soothing for throats, and supportive to growth of the immune system. The rising health consciousness, and rising demand for natural products like these are expected to create major opportunities for players in the propolis market in the near future.

An international team of researchers have made a significant discovery that can change the fortunes of several players in the propolis market in the near future. These researchers have found that adding 4kg-1 to the diets of fishes resulted in best survival rates in cold climatic conditions. This study published in Aquculture journal was conducted by researchers from the National institute of Ocanography and Fisheries.

The study experimented with Nile Tilapia fish. The rising demand for fish products, and growing threats of extinctions to various fish species is a major concern for the fishing industry worldwide. This study and potential of propolis use in the industry is a major potential upturn for the propolis market.

The Global Propolis Market: Drivers and Restraints

The global propolis market is expected to witness robust growth in the near future, thanks to rising demand for alternative medicine, growing demand for natural food products, and increased reliance on the substance for a wide variety of medical needs. The rising cases of burn victims due to rising instances of forest fires and urban fire outbreaks are also a major factor boosting demand in the propolis market. The demand from the healthcare sector for treating severe burn wounds is likely to rise in the near future. Additionally, propolis is also used for a variety of common conditions like treating sore throats, soothing voice chords, etc. The increasing reliance, the cost-effectiveness of alternative treatments, and increasing move by patients to prefer alternative healthcare options at retail clinics are expected to remain major drivers of growth.

The Global Propolis Market: Geographical Analysis

The global propolis market is expected to witness major growth in North America region. The growing demand for alternative medicine, growing demand for natural food products, and increasing awareness of the substance are expected to drive significant growth. The propolis market is also expected to register significant growth in Asia Pacific region. The significant rise in disposable incomes, large population, and traditional use of propolis in medicine are expected to register significant growth for the market in the region.

Request For TOC On this Market Report at https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6079

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read more:

Propolis Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2028 - Redhill Local Councillors

As more and more states legalize marijuana, more and more people are using it. Use in pregnant women and women who breastfeed is also on the rise. This can be concerning since studies have demonstrated daily cannabis use during pregnancy can be harmful. For example, studies have established a low birth weight with use. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis. THC is able to cross the placenta during pregnancy as well as pass through breast milk during feeding.

A study published in the Journal of Addiction Medicine evaluated the perceptions of cannabis use in pregnancy and breastfeeding. This study was the first to evaluate perceptions from the patients perspectives as well as being conducted in a state with legal recreational cannabis use. The investigators interviewed 19 women in Washington state, 14 were pregnant and five were postpartum. All 19 women used cannabis on a daily basis or occasionally.

The researchers found five common themes among the women interviewed. First, some women stated they used cannabis to control other conditions such as anxiety, nausea, pain, and stress. For example, one woman stated it allowed her to keep food down during pregnancy. Women also expressed concern for their baby.

Second, women were evaluating the need for cannabis throughout their stages of pregnancy and believed it was safer than alternative prescription drugs.

Third, women were receiving mixed messages from their providers. Some providers told them to stop, some asked them to cut back on use, while others didnt address the topic at all when it was brought up by the patient.

Fourth, women wanted more information regarding the safety and concerns of daily cannabis use during pregnancy.

Fifth, some women were concerned about being drug tested and potential consequences from child protective services.

This study is unique in that it gives insight to patients perspectives, which is vital when providers evaluate patients needs and concerns. The researchers recommend a harm reduction approach, which suggests cutting back on cannabis use compared to the cold turkey alternative. It is also important that national guidelines are followed by providers, which state that risks of cannabis use during pregnancy and postpartum should be explained to patients. It is important to engage in shared decision-making while decreasing stigma.

Written by Kayla Dillon, BS

References:

Image byBoris GonzalezfromPixabay

See the article here:

Perceptions of daily cannabis use during pregnancy - Medical News Bulletin